4//SEC Filing
Yazji Salim 4
Accession 0001209191-23-024371
CIK 0001260990other
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 6:02 PM ET
Size
7.7 KB
Accession
0001209191-23-024371
Insider Transaction Report
Form 4
Yazji Salim
Chief Medical Officer
Transactions
- Purchase
Common Stock
2023-04-13$0.28/sh+10,000$2,850→ 159,676 total - Purchase
Common Stock
2023-04-14$0.30/sh+5,000$1,500→ 164,676 total - Purchase
Common Stock
2023-04-12$0.28/sh+10,000$2,850→ 149,676 total
Documents
Issuer
Oncternal Therapeutics, Inc.
CIK 0001260990
Entity typeother
Related Parties
1- filerCIK 0001864486
Filing Metadata
- Form type
- 4
- Filed
- Apr 13, 8:00 PM ET
- Accepted
- Apr 14, 6:02 PM ET
- Size
- 7.7 KB